Kin T, Nakajima Y, Kanehiro H, Hisanaga M, Ohyama T, Nishio K, Sho M, Nagao M, Nakano H
First Department of Surgery, Nara Medical University, Japan.
World J Surg. 1998 Oct;22(10):1087-91. doi: 10.1007/s002689900522.
Recurrence rates after hepatic resection in patients with colorectal metastases are reported to range from 47% to 80%. Hepatic recurrence is seen in 35% to 50% of patients. Aggressive surgical resection appears to be a worthwhile treatment in patients with recurrent hepatic metastases to promote longer patient survival because surgical resection remains the only curative therapy available. This is a retrospective review of our experience with 15 patients undergoing repeat hepatic resection culled from 67 patients undergoing initial hepatectomy for metastatic colorectal cancer. Of 67 patients who underwent hepatectomy for colorectal hepatic metastases, 33 developed hepatic recurrence at a median interval of 23 months (range 1-176 months) after the first hepatectomy. The second hepatectomy was performed in 15 patients 5 to 29 months after the first hepatectomy, with no mortality. The mean operating time and blood loss at the second hepatectomy were similar to those at the first hepatectomy. The mean hospital stay at the second hepatectomy was significantly shorter than that at the first hepatectomy. The cumulative survival rate for the 15 patients was 42.4% at 3 years and 21.2% at 5 years, respectively, which compared favorably with the survival rate of the 67 patients who underwent initial hepatectomy. Patients who underwent the second hepatectomy had significantly higher survival rates from the first hepatectomy than the 18 patients with unresectable hepatic recurrence. Repeat hepatectomy can be performed safely and provides long-term survival rates similar to those of first hepatectomies. In appropriately selected patients, repeat hepatectomy for colorectal metastases is a worthwhile treatment.
据报道,结直肠癌肝转移患者肝切除术后的复发率在47%至80%之间。35%至50%的患者会出现肝复发。积极的手术切除对于复发性肝转移患者似乎是一种值得尝试的治疗方法,因为手术切除仍然是唯一可用的治愈性疗法,有助于延长患者生存期。这是一项对15例接受再次肝切除患者的回顾性研究,这些患者是从67例因转移性结直肠癌接受初次肝切除的患者中挑选出来的。在67例因结直肠癌肝转移接受肝切除的患者中,33例出现肝复发,首次肝切除术后的中位间隔时间为23个月(范围1 - 176个月)。15例患者在首次肝切除术后5至29个月接受了第二次肝切除,无死亡病例。第二次肝切除的平均手术时间和失血量与首次肝切除相似。第二次肝切除的平均住院时间明显短于首次肝切除。15例患者的3年累计生存率分别为42.4%,5年累计生存率为21.2%,与67例接受初次肝切除患者的生存率相比具有优势。接受第二次肝切除的患者自首次肝切除后的生存率明显高于18例不可切除肝复发患者。再次肝切除可以安全进行,并且提供与首次肝切除相似的长期生存率。对于经过适当选择的患者,结直肠癌转移的再次肝切除是一种值得尝试的治疗方法。